Resultados de la búsqueda 1-10 of 16790 for Hepatic steatosis
AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025; doi:0.1097/HEP ...
Accessed May 11, 2023. Nonalcoholic fatty liver disease (NAFLD) and NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.
Nonalcoholic fatty liver disease (adult). Mayo Clinic; 2022. Thomas RA. Allscripts EPSi. Mayo Clinic. May 25, 2023. Medical review (expert opinion). Mayo Clinic ...
... liver's structure and function, increasing the risk of liver failure and liver cancer. ... liver disease assessment of hepatic fibrosis and steatosis. Hepatology.
Cirrhosis can develop from many causes, including long-term alcohol use, viral hepatitis and fatty liver disease, also called metabolic dysfunction-associated ...
Nonalcoholic fatty liver disease (NAFLD). Merck Manual Professional Version. https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/approach-to ...
Hepatic encephalopathy may be caused by injury to the liver, cancer or a chronic liver disease that results in liver failure, such as cirrhosis. Hepatic ...
Hepatic encephalopathy is diagnosed by looking at the medical history, signs and symptoms, medicine use, and the results of blood tests and other tests. Tests ...
2022.03.010. Nonalcoholic fatty liver disease (NAFLD). American Liver Foundation. https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic- ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?